P2RY12 and neoplasm: In this setting, the P2Y12 antagonist, given by gavage at a dosage of 100mg/Kg, restrained tumor growth by 60% compared with aspirin administered at 150 mg/kg and by 75% compared with a vehicle (phosphate-buffered saline, 200 mL).